Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1989 2
1990 5
1992 1
1993 1
1994 1
1996 2
1999 3
2001 4
2002 2
2003 3
2004 2
2005 1
2007 2
2008 10
2009 4
2010 8
2011 6
2012 4
2013 3
2014 1
2015 2
2016 1
2019 1
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

63 results

Results by year

Filters applied: . Clear all
Page 1
Phase III trial of carboplatin and paclitaxel compared with cisplatin and paclitaxel in patients with optimally resected stage III ovarian cancer: a Gynecologic Oncology Group study.
Ozols RF, Bundy BN, Greer BE, Fowler JM, Clarke-Pearson D, Burger RA, Mannel RS, DeGeest K, Hartenbach EM, Baergen R; Gynecologic Oncology Group. Ozols RF, et al. Among authors: degeest k. J Clin Oncol. 2003 Sep 1;21(17):3194-200. doi: 10.1200/JCO.2003.02.153. Epub 2003 Jul 14. J Clin Oncol. 2003. PMID: 12860964 Corrected and republished. Clinical Trial.
Rhabdomyosarcoma of the uterus in a postmenopausal patient.
Podczaski E, Sees J, Kaminski P, Sorosky J, Larson JE, DeGeest K, Zaino RJ, Mortel R. Podczaski E, et al. Among authors: degeest k. Gynecol Oncol. 1990 Jun;37(3):439-42. doi: 10.1016/0090-8258(90)90384-w. Gynecol Oncol. 1990. PMID: 2190875 Review.
Paraneoplastic thrombocytosis in ovarian cancer.
Stone RL, Nick AM, McNeish IA, Balkwill F, Han HD, Bottsford-Miller J, Rupairmoole R, Armaiz-Pena GN, Pecot CV, Coward J, Deavers MT, Vasquez HG, Urbauer D, Landen CN, Hu W, Gershenson H, Matsuo K, Shahzad MM, King ER, Tekedereli I, Ozpolat B, Ahn EH, Bond VK, Wang R, Drew AF, Gushiken F, Lamkin D, Collins K, DeGeest K, Lutgendorf SK, Chiu W, Lopez-Berestein G, Afshar-Kharghan V, Sood AK. Stone RL, et al. Among authors: degeest k. N Engl J Med. 2012 Feb 16;366(7):610-8. doi: 10.1056/NEJMoa1110352. N Engl J Med. 2012. PMID: 22335738 Free PMC article. Clinical Trial.
Diurnal cortisol and survival in epithelial ovarian cancer.
Schrepf A, Thaker PH, Goodheart MJ, Bender D, Slavich GM, Dahmoush L, Penedo F, DeGeest K, Mendez L, Lubaroff DM, Cole SW, Sood AK, Lutgendorf SK. Schrepf A, et al. Among authors: degeest k. Psychoneuroendocrinology. 2015 Mar;53:256-67. doi: 10.1016/j.psyneuen.2015.01.010. Epub 2015 Jan 20. Psychoneuroendocrinology. 2015. PMID: 25647344 Free PMC article.
Isolated vaginal recurrences of endometrial carcinoma.
Morgan JD 3rd, Reddy S, Sarin P, Yordan E, DeGeest K, Hendrickson FR. Morgan JD 3rd, et al. Among authors: degeest k. Radiology. 1993 Nov;189(2):609-13. doi: 10.1148/radiology.189.2.8210396. Radiology. 1993. PMID: 8210396
SSRI use and clinical outcomes in epithelial ovarian cancer.
Christensen DK, Armaiz-Pena GN, Ramirez E, Matsuo K, Zimmerman B, Zand B, Shinn E, Goodheart MJ, Bender D, Thaker PH, Ahmed A, Penedo FJ, DeGeest K, Mendez L, Domann F, Sood AK, Lutgendorf SK. Christensen DK, et al. Among authors: degeest k. Oncotarget. 2016 May 31;7(22):33179-91. doi: 10.18632/oncotarget.8891. Oncotarget. 2016. PMID: 27121207 Free PMC article.
The role of LEF1 in endometrial gland formation and carcinogenesis.
Shelton DN, Fornalik H, Neff T, Park SY, Bender D, DeGeest K, Liu X, Xie W, Meyerholz DK, Engelhardt JF, Goodheart MJ. Shelton DN, et al. Among authors: degeest k. PLoS One. 2012;7(7):e40312. doi: 10.1371/journal.pone.0040312. Epub 2012 Jul 6. PLoS One. 2012. PMID: 22792274 Free PMC article.
The addition of paclitaxel to doxorubicin and cisplatin and volume-directed radiation does not improve overall survival (OS) or long-term recurrence-free survival (RFS) in advanced endometrial cancer (EC): A randomized phase III NRG/Gynecologic Oncology Group (GOG) study.
Spirtos NM, Enserro D, Homesley HD, Gibbons SK, Cella D, Morris RT, DeGeest K, Lee RB, Miller DS. Spirtos NM, et al. Among authors: degeest k. Gynecol Oncol. 2019 Jul;154(1):13-21. doi: 10.1016/j.ygyno.2019.03.240. Epub 2019 Apr 30. Gynecol Oncol. 2019. PMID: 31053405 Free PMC article. Clinical Trial.
63 results